Related Experiment Videos

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy: who and how? - Authors' reply

Linda M Henricks1, Carin A T C Lunenburg2, Annemieke Cats3

  • 1Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, Netherlands.

The Lancet. Oncology
|February 5, 2019
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos